---
title: "Nurtec ODT (rimegepant), all indications: Safety questions"
description: "Safety questions on Nurtec ODT (rimegepant) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Warnings. Questions: Who should not take Nurtec ODT (contraindications)? Can Nurtec ODT cause allergic reactions? Can Nurtec ODT raise blood pressure? Can Nurtec ODT cause Raynaud's phenomenon? 4 questions quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/nurtec-odt/safety"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Nurtec ODT (rimegepant), all indications: Safety questions

Manufacturer: Pfizer Inc  
Prescribing information: [Nurtec ODT](https://labeling.pfizer.com/ShowLabeling.aspx?id=19036)  
Indication pages: [Acute treatment of migraine](https://www.evicenter.com/medical-information/nurtec-odt--acute-treatment-of-migraine)

## Warnings

<a id="nurtec-contraindications"></a>

### Who should not take Nurtec ODT (contraindications)?

> “NURTEC ODT is contraindicated in patients with a history of hypersensitivity reaction to rimegepant, NURTEC ODT, or any of its components. Reactions have included anaphylaxis and delayed serious hypersensitivity [see Warnings and Precautions (5.1)].”

Source: [NURTEC ODT: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19036#:~:text=NURTEC%20ODT%20is%20contraindicated%20in,%5Bsee%20Warnings%20and%20Precautions%20%285.1%29%5D.)

<a id="nurtec-allergic-reactions"></a>

### Can Nurtec ODT cause allergic reactions?

> “Serious hypersensitivity reactions, including anaphylaxis, dyspnea, and rash, have occurred in patients treated with NURTEC ODT. Hypersensitivity reactions can occur days after administration, and delayed serious hypersensitivity has occurred. If a hypersensitivity reaction occurs, discontinue NURTEC ODT and initiate appropriate therapy [see Contraindications (4) and Adverse Reactions (6.1, 6.2)].”

Source: [NURTEC ODT: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19036#:~:text=Serious%20hypersensitivity%20reactions%2C%20including%20anaphylaxis%2C,and%20Adverse%20Reactions%20%286.1%2C%206.2%29%5D.)

> “Inform patients about the signs and symptoms of hypersensitivity reactions and that these reactions can occur days after administration of NURTEC ODT. Advise patients to contact their healthcare provider immediately if signs or symptoms of hypersensitivity reactions occur [see Warnings and Precautions (5.1)].”

Source: [NURTEC ODT: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19036#:~:text=Inform%20patients%20about%20the%20signs,%5Bsee%20Warnings%20and%20Precautions%20%285.1%29%5D.)

<a id="nurtec-high-blood-pressure"></a>

### Can Nurtec ODT raise blood pressure?

> “Development of hypertension and worsening of pre-existing hypertension have been reported following the use of CGRP antagonists, including NURTEC ODT, in the postmarketing setting.
>
> Some of the patients who developed new-onset hypertension had risk factors for hypertension. There were cases requiring initiation of pharmacological treatment for hypertension and, in some cases, hospitalization. Hypertension may occur at any time during treatment, but was most frequently reported within 7 days of therapy initiation. NURTEC ODT was discontinued in many of the reported cases.
>
> Monitor patients treated with NURTEC ODT for new-onset hypertension or worsening of pre-existing hypertension, and consider whether discontinuation of NURTEC ODT is warranted if evaluation fails to establish an alternative etiology or blood pressure is inadequately controlled.”

Source: [NURTEC ODT: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19036#:~:text=Development%20of%20hypertension%20and%20worsening,blood%20pressure%20is%20inadequately%20controlled.)

Note: The label describes postmarketing reports for the CGRP antagonist class, including Nurtec ODT.

<a id="nurtec-raynauds"></a>

### Can Nurtec ODT cause Raynaud's phenomenon?

> “Development of Raynaud’s phenomenon and recurrence or worsening of pre-existing Raynaud’s phenomenon have been reported in the postmarketing setting following the use of CGRP antagonists, including NURTEC ODT.
>
> In reported cases with small molecule CGRP antagonists, symptom onset occurred a median of 1.5 days following dosing. Many of the cases reported serious outcomes, including hospitalizations and disability, generally related to debilitating pain. In most reported cases, discontinuation of the CGRP antagonist resulted in resolution of symptoms.
>
> NURTEC ODT should be discontinued if signs or symptoms of Raynaud’s phenomenon develop, and patients should be evaluated by a healthcare provider if symptoms do not resolve. Patients with a history of Raynaud’s phenomenon should be monitored for, and informed about the possibility of, worsening or recurrence of signs and symptoms.”

Source: [NURTEC ODT: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19036#:~:text=Development%20of%20Raynaud%E2%80%99s%20phenomenon%20and,recurrence%20of%20signs%20and%20symptoms.)

Note: The label describes postmarketing reports for the CGRP antagonist class, including Nurtec ODT; the symptom-onset figure is from reported cases with small molecule CGRP antagonists.

## Related pages
- [Medical information: Nurtec ODT (rimegepant): All indications](https://www.evicenter.com/medical-information/nurtec-odt)
- [Indication](https://www.evicenter.com/medical-information/nurtec-odt/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/nurtec-odt/pharmacology)
- [Specific populations](https://www.evicenter.com/medical-information/nurtec-odt/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/nurtec-odt/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/nurtec-odt/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/nurtec-odt/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/nurtec-odt/access-and-coverage)
